Kymera Therapeutics
Healthcare & Life SciencesDirect Greenhouse career site

Senior Director, Early Phase Formulation Development

Pay
$235,000 – $330,000 per year
Location
Watertown, MA · On-site
Job type
Full-time
Level
Director
Experience
15+ years
Education
Doctorate
Listed
Today

Skills & highlights for this role

  • preformulation characterization
  • formulation of poorly soluble compounds
  • GMP
  • IND-enabling development

Also useful

  • CRO/CDMO management

Stated benefits & perks

  • Health
  • Equity
  • Annual bonus
Free · No account needed

How well does your resume fit this job?

Upload your resume to see your score for this Kymera Therapeutics role, what matches, what's missing, and your best other matches.

Scored on our server and not saved there. The file stays in this browser so you don't have to upload it again after you sign up.

How we work

  • PIONEER: We are courageous, resilient and rigorous in our mission to improve patients' lives through our revolutionary degrader medicines.
  • COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
  • BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.

How you'll make an impact

The Senior Director of Early Phase Formulation Development will provide scientific leadership for preformulation and early stage formulation activities across our portfolio of small molecule programs.

This individual will serve as a hands-on scientific expert and team leader, driving enabling formulation strategies from candidate selection through early clinical development, with a focus on solving complex drug delivery and bioavailability challenges inherent to degrader molecules.

The successful candidate will partner closely with Research, DMPK, and CMC functions to advance programs efficiently through IND and into early-stage clinical studies. This role requires deep scientific expertise in enabling formulation technologies, a strong track record in early-stage pharmaceutical development, and the ability to work collaboratively across functions in a fast-paced biotech environment.

Responsibilities

  • Lead early formulation development activities across programs, providing scientific direction on preformulation characterization, enabling formulation strategies, and drug product design for preclinical and early clinical stages
  • Apply deep scientific expertise in preformulation, biopharmaceutics, and enabling formulation technologies to support candidate progression decisions and advance programs from discovery through IND
  • Drive innovation in enabling formulation technologies to address solubility and bioavailability challenges across the early pipeline
  • Design and execute phase-appropriate formulation and drug product development strategies for preclinical toxicology studies and early clinical programs
  • Provide scientific and technical guidance; coordinate with external CROs and CDMOs to execute early formulation and drug product programs
  • Contribute to establishing phase-appropriate best practices, SOPs, and experimental frameworks for early formulation development activities
  • Manage outsourced early formulation and drug product activities with CROs and CDMOs, ensuring scientific quality, timelines, and technical objectives are met
  • Support CMC regulatory strategy for drug product development and contribute to preparation of drug product IND sections
  • Ensure compliance with applicable GMP and regulatory requirements

Skills and experience you'll bring

  • Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemical Engineering, or related discipline with 15+ years of relevant pharmaceutical industry experience, with a focus on early-stage formulation development
  • Demonstrated scientific expertise in early-stage pharmaceutical development, with a track record of advancing small molecule programs from discovery through IND and into clinical development
  • Strong understanding of preformulation, biopharmaceutics, formulation development, and oral solid dose drug product manufacturing for small molecules
  • Deep expertise in formulation approaches for poorly soluble compounds, including application of enabling technologies to improve bioavailability and product performance
  • Proven track record of advancing small molecule programs through IND, with hands-on expertise in preformulation characterization, enabling formulation development, and early clinical drug product design
  • Strong knowledge of GMP requirements, regulatory expectations, and evolving industry trends
  • Experience coordinating with external CROs and CDMOs to deliver formulation development objectives
  • Strong scientific communication skills and ability to collaborate effectively with cross-functional teams and external partners

Compensation

  • Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay.
  • The anticipated base salary range for this role is $235,000 - $330,000, with eligibility for annual bonus, equity participation, and comprehensive benefits.
  • Actual salary is based on a holistic evaluation of the specific role/level as well as each candidate's depth of experience and the capabilities they bring to the position.

Who we are

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics.

Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years.

Read the original posting

From Kymera Therapeutics's careers page, first listed on Rolev.ai on November 19, 2026. Rolev.ai is not the employer.

How Rolev.ai helps with this application

Rolev.ai is a job search and application tool for US job seekers. For this Senior Director, Early Phase Formulation Development role at Kymera Therapeutics, it shows how your resume fits, tailors your resume to the posting, and prepares the application for you to review.

  • See how you fit

    Openings from employer career sites are ranked against your whole resume—and searchable inside Claude, ChatGPT, and Cursor via Rolev.ai MCP.

  • Tailor without inventing

    Every change to your resume is checked against your original. New experience goes in only with your yes—zero fabricated claims.

  • Draft the full kit

    Tailored and Full Match resumes, role-specific cover letters, and answers to employer screening questions are prepared in seconds.

  • 1-Click Extension Autofill

    The Chrome extension fills the employer's Greenhouse, Workday, Lever, or Ashby form in 1 click. You review it and press Submit.

Common questions

What is the salary for the Senior Director, Early Phase Formulation Development role at Kymera Therapeutics?

The Senior Director, Early Phase Formulation Development posting at Kymera Therapeutics states compensation of $235,000 – $330,000 per year. It is listed as a full-time position. Final pay may depend on location, experience, and interview evaluation on Kymera Therapeutics's official career site.

Where is the Senior Director, Early Phase Formulation Development job at Kymera Therapeutics located?

This Senior Director, Early Phase Formulation Development position at Kymera Therapeutics is located in Watertown, MA (On-site). Always check Kymera Therapeutics's application page for specific state eligibility or relocation policies.

What qualifications are required for Senior Director, Early Phase Formulation Development at Kymera Therapeutics?

For the Senior Director, Early Phase Formulation Development role, Kymera Therapeutics highlights 15+ years of relevant experience; a doctorate; experience with preformulation characterization, formulation of poorly soluble compounds, GMP, IND-enabling development. Rolev.ai can score your existing resume against these requirements and show any skill gaps before you apply.

How do I apply for the Senior Director, Early Phase Formulation Development position at Kymera Therapeutics?

This listing links directly to Kymera Therapeutics's Greenhouse application page. You can apply directly on Kymera Therapeutics's site, or use Rolev.ai to check your resume fit, generate a zero-hallucination tailored resume and cover letter for this posting, and autofill the Greenhouse application form in 1 click with the Rolev.ai Chrome extension. You always review the form and press Submit yourself.